Drug Type Small molecule drug |
Synonyms FR264205 |
Target |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H32N12O12S3 |
InChIKeyUJDQGRLTPBVSFN-TVNHLQOTSA-N |
CAS Registry936111-69-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pseudomonas aeruginosa infection | Preclinical | JP | 01 Mar 2007 |